• Je něco špatně v tomto záznamu ?

Transcriptomic Signatures of Antibody-mediated Rejection in Early Biopsies With Negative Histology in HLA-incompatible Kidney Transplantation

P. Hruba, J. Klema, P. Mrazova, E. Girmanova, K. Jaklova, L. Voska, M. Kment, M. Mackova, K. Osickova, V. Hanzal, PF. Halloran, O. Viklicky

. 2025 ; 11 (1) : e1741. [pub] 20241213

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25001881

BACKGROUND: Presensitized patients with circulating donor-specific antibodies (DSAs) before transplantation are at risk for antibody-mediated rejection (AMR). Peritransplant desensitization mitigates but does not eliminate the alloimmune response. We examined the possibility that subthreshold AMR activity undetected by histology could be operating in some early biopsies. METHODS: Transcriptome of kidney allograft biopsies performed within the first month in presensitized patients (DSA+) who had received desensitization and did not develop active/probable AMR by histology (R-) was compared with biopsies showing active/probable AMR (R+/DSA+). As negative controls, biopsies without rejection by histology in patients without DSA at transplantation were used (R-/DSA-). RNA sequencing from biopsies selected from the biobank was used in cohort 1 (n = 32) and microarray, including the molecular microscope (Molecular Microscope Diagnostic System [MMDx]) algorithm, in recent cohort 2 (n = 30). RESULTS: The transcriptome of R-/DSA+ was similar to R+/DSA+ as these groups differed in 14 transcripts only. Contrarily, large differences were found between both DSA+ groups and negative controls. Fast gene set enrichment analyses showed upregulation of the immune system in both DSA+ groups (gene ontology terms: adaptive immune response, humoral immune response, antigen receptor-mediated signaling, and B-cell receptor signaling or complement activation) when compared with negative controls. MMDx assessment in cohort 2 classified 50% of R-/DSA+ samples as AMR and found no differences in AMR molecular scores between R+ and R- DSA+ groups. In imlifidase desensitization, MMDx series showed a gradual increase in AMR scores over time. CONCLUSIONS: Presensitized kidney transplant recipients exhibited frequent molecular calls of AMR in biopsy-based transcript diagnostics despite desensitization therapy and negative histology.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25001881
003      
CZ-PrNML
005      
20250123101950.0
007      
ta
008      
250117s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/TXD.0000000000001741 $2 doi
035    __
$a (PubMed)39687512
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hruba, Petra $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/000000028663413X
245    10
$a Transcriptomic Signatures of Antibody-mediated Rejection in Early Biopsies With Negative Histology in HLA-incompatible Kidney Transplantation / $c P. Hruba, J. Klema, P. Mrazova, E. Girmanova, K. Jaklova, L. Voska, M. Kment, M. Mackova, K. Osickova, V. Hanzal, PF. Halloran, O. Viklicky
520    9_
$a BACKGROUND: Presensitized patients with circulating donor-specific antibodies (DSAs) before transplantation are at risk for antibody-mediated rejection (AMR). Peritransplant desensitization mitigates but does not eliminate the alloimmune response. We examined the possibility that subthreshold AMR activity undetected by histology could be operating in some early biopsies. METHODS: Transcriptome of kidney allograft biopsies performed within the first month in presensitized patients (DSA+) who had received desensitization and did not develop active/probable AMR by histology (R-) was compared with biopsies showing active/probable AMR (R+/DSA+). As negative controls, biopsies without rejection by histology in patients without DSA at transplantation were used (R-/DSA-). RNA sequencing from biopsies selected from the biobank was used in cohort 1 (n = 32) and microarray, including the molecular microscope (Molecular Microscope Diagnostic System [MMDx]) algorithm, in recent cohort 2 (n = 30). RESULTS: The transcriptome of R-/DSA+ was similar to R+/DSA+ as these groups differed in 14 transcripts only. Contrarily, large differences were found between both DSA+ groups and negative controls. Fast gene set enrichment analyses showed upregulation of the immune system in both DSA+ groups (gene ontology terms: adaptive immune response, humoral immune response, antigen receptor-mediated signaling, and B-cell receptor signaling or complement activation) when compared with negative controls. MMDx assessment in cohort 2 classified 50% of R-/DSA+ samples as AMR and found no differences in AMR molecular scores between R+ and R- DSA+ groups. In imlifidase desensitization, MMDx series showed a gradual increase in AMR scores over time. CONCLUSIONS: Presensitized kidney transplant recipients exhibited frequent molecular calls of AMR in biopsy-based transcript diagnostics despite desensitization therapy and negative histology.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Klema, Jiri $u Department of Computer Science, Czech Technical University, Prague, Czech Republic $1 https://orcid.org/0000000317539435 $7 ntka172916
700    1_
$a Mrazova, Petra $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000248830471
700    1_
$a Girmanova, Eva $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000231152221
700    1_
$a Jaklova, Katerina $u Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Voska, Ludek $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000162818973
700    1_
$a Kment, Martin $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000179764377
700    1_
$a Mackova, Martina $u Department of Medicine, University of Alberta, Edmonton, AB, Canada
700    1_
$a Osickova, Klara $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Hanzal, Vladimir $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Halloran, Philip F $u Department of Medicine, University of Alberta, Edmonton, AB, Canada $u Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada
700    1_
$a Viklicky, Ondrej $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000310492195 $7 nlk20050170291
773    0_
$w MED00195744 $t Transplantation direct $x 2373-8731 $g Roč. 11, č. 1 (2025), s. e1741
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39687512 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123101944 $b ABA008
999    __
$a ok $b bmc $g 2254414 $s 1237884
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 11 $c 1 $d e1741 $e 20241213 $i 2373-8731 $m Transplantation direct $n Transplant Direct $x MED00195744
LZP    __
$a Pubmed-20250117

Najít záznam

Citační ukazatele

Možnosti archivace